Literature DB >> 16867455

ELISA for quantitation of tumor necrosis factor-alpha in serum.

W S Prince1, K J Harder, S Saks, B R Reed, A B Chen, A J Jones.   

Abstract

A sensitive and precise ELISA has been developed for the quantitation of recombinant Tumor Necrosis Factor-Alpha (rTNF-alpha) in undiluted sera. Affinity purified rabbit antibody was used as capture antibody and mouse monoclonal antibody labelled with horseradish peroxidase was used as the second antibody in a sandwich ELISA. The assay range was from 50 to 2000 pg/ml and the relative standard deviation was 8% or less for both interassay and intra-assay precision studies. Recovery of rTNF-alpha added to 10 different human and 10 different monkey sera ranged from 81 to 102% and 100 to 120% of the expected value, respectively. This ELISA has been used to measure serum rTNF-alpha levels in over 60 patients in Phase I Clinical Trials treated with rTNF-alpha. The levels in a representative, pharmacokinetic study showed low variability between 8 patients receiving intravenous bolus administration of 100 mu rTNF-alpha/m(2). The ELISA results correlated well with TNF bioassay data with a mean specific activity of 2.5 x 10(7) U/mg.

Entities:  

Year:  1987        PMID: 16867455     DOI: 10.1016/0731-7085(87)80097-3

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  5 in total

1.  Tumour necrosis factor-alpha in infectious meningitis.

Authors:  D Nadal; D Leppert; K Frei; P Gallo; H Lamche; A Fontana
Journal:  Arch Dis Child       Date:  1989-09       Impact factor: 3.791

2.  Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor alpha: relevance to genetic predisposition to systemic lupus erythematosus.

Authors:  C O Jacob; Z Fronek; G D Lewis; M Koo; J A Hansen; H O McDevitt
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

3.  The endogenous induction of tumor necrosis factor serum (TNS) for the adjuvant postoperative immunotherapy of cancer--changes in immunological markers of the blood.

Authors:  Y Abe; M Miyake; T Miyazaki; A Horiuchi; S Kimura
Journal:  Jpn J Surg       Date:  1990-01

4.  A fast universal immobilization of immunoglobulin G at 4 °C for the development of array-based immunoassays.

Authors:  Shu-Lin Guo; Po-Chung Chen; Ming-Shuo Chen; Yu-Che Cheng; Jun-Mu Lin; Hoong-Chien Lee; Chien-Sheng Chen
Journal:  PLoS One       Date:  2012-12-07       Impact factor: 3.240

5.  Liver and tumour tissue concentrations of TNF-alpha in cancer patients treated with TNF-alpha and melphalan by isolated liver perfusion.

Authors:  P J Kuppen; L E Jonges; C J van de Velde; A L Vahrmeijer; R A Tollenaar; I H Borel Rinkes; A M Eggermont
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.